Delivery Order SPE2DB22D2206-SPE2DB25FFN46
Award Date
2/10/25
Potential Completion Date
2/11/25
Potential Value
$3.4K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award from the Defense Logistics Agency (DLA) was issued to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,575.64 firm fixed-price delivery order contract is for the supply of Candesartan Cilexetil 16 mg Tablets, a cardiovascular medication, to support military healthcare programs. The contract has a period of performance through January 3, 2025. Amerisourcebergen holds a larger $999,999,999 Indefinite Delivery...
This federal contract award, valued at $8,333.90, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Candesartan Cilexetil 32 mg tablets, a cardiovascular medication, with a completion date of December 17, 2024. This contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 between Amerisourcebergen and the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $3,247.80, is for the delivery of Candesartan Cilexetil 8mg tablets. It is a firm fixed-price delivery order contract with a completion date of September 17, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued at up...
This federal contract award, valued at $4,463.03, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Candesartan Cilexetil 8 mg tablets, a medication used to treat high blood pressure and heart failure. The award is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at...
This federal contract award, valued at $7,632.10, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of Candesartan Cilexetil 16 mg tablets, a cardiovascular medication. The contract has an ultimate completion date of October 23, 2024 and was awarded on October 22, 2024. It is a firm fixed-price contract, with no set-aside designation....
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major supplier of pharmaceutical products and medical supplies to the U.S. government. The $5,534.12 firm fixed-price delivery order is for the supply of Candesartan Cilexetil 8 mg tablets, a medication used to treat high blood pressure and heart failure. The award falls under a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,089.38 firm fixed-price delivery order is for the supply of 90-count bottles of 32mg Candesartan Cilexetil tablets. The contract has an ultimate completion date of October 10, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Candesartan Cilexetil 4 mg tablets, a cardiovascular medication, with a ceiling value of $1,216.52 and a completion date of February 3, 2025. This award is a delivery order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with...
This federal contract award, valued at $4,744.06, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract is for the delivery of Candesartan Cilexetil 16 mg tablets, a cardiovascular medication, to support military healthcare programs. Amerisourcebergen, a major pharmaceutical distributor, holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This federal contract award is for the delivery of Candesartan Cilexetil 8 mg tablets in 90-count packages. The award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a...